日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosage

一种靶向前列腺特异性膜抗原的小分子药物偶联物,可用于低剂量高效治疗前列腺癌。

Zhang, Jingjing; Hu, Fanchun; Deng, Caiting; Ding, Yuhan; Yang, Yuchen; Han, Shupeng; Liu, Jun; An, Feifei; Shi, Mingsong

pH-Dependent Assembly and Stability of Toll-Like Receptor 3/dsRNA Signaling Complex: Insights from Constant pH Molecular Dynamics and Metadynamics Simulations

Toll样受体3/dsRNA信号复合物的pH依赖性组装和稳定性:来自恒定pH分子动力学和元动力学模拟的启示

Li, Penghui; Shi, Mingsong; Wang, Yibo; Liu, Qiong; Du, Xiubo; Wang, Xiaohui

Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases

纳米技术驱动的鼻内疫苗递送系统在对抗传染病方面的进展

Zhang, Zhihan; Yang, Yumeng; Huang, Liwen; Yuan, Lei; Huang, Sijian; Zeng, Zihang; Cao, Yuan; Wei, Xianghong; Wang, Xiaomei; Shi, Mingsong; Zhong, Maohua

Effects and Safety of Press-Needle Therapy for Improving Visual Function and Eye Blood Circulation in Patients With Glaucoma With Controlled Intraocular Pressure: Study Protocol for a Multicenter Randomized Controlled Trial

压针疗法改善眼压控制良好青光眼患者视觉功能和眼部血液循环的效果和安全性:一项多中心随机对照试验的研究方案

Liu, Hongji; Dai, Yan; Yu, Ming; Zeng, Jian; Wang, Chao; Tan, Sa; Xiong, Ming; Zhang, Ran; Yu, Xuemeng; Shi, Mingsong; Yan, Xing; Lai, Fengming

Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2(V617F)-induced myeloproliferative neoplasms

更正:新型 JAK2/FLT3 抑制剂马来酸氟诺替尼治疗 JAK2(V617F) 诱导的骨髓增生性肿瘤的临床前研究

Hu, Mengshi; Yang, Tao; Yang, Linyu; Niu, Lu; Zhu, Jinbing; Zhao, Ailin; Shi, Mingsong; Yuan, Xue; Tang, Minghai; Yang, Jianhong; Pei, Heying; Yang, Zhuang; Chen, Qiang; Ye, Haoyu; Niu, Ting; Chen, Lijuan

Elucidating the linagliptin and fibroblast activation protein binding mechanism through molecular dynamics and binding free energy analysis.

通过分子动力学和结合自由能分析阐明利格列汀与成纤维细胞活化蛋白的结合机制

Shi Mingsong, Wang Fang, Lu Zhou, Yin Yuan, Zheng Xueting, Wang Decai, Cai Xianfu, Jing Meng, Wang Jianjun, Chen Junxian, Jiang Xile, Yu Wenliang, Li Xiaoan

Lactylation: The emerging frontier in post-translational modification

乳酸化:翻译后修饰领域的新兴前沿

Lu, Zhou; Zheng, Xueting; Shi, Mingsong; Yin, Yuan; Liang, Yuanyuan; Zou, Zhiyan; Ding, Chenghe; He, Yuanjing; Zhou, Yan; Li, Xiaoan

Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation

用于药物验证的非消退性先天性血管瘤的新型类器官构建策略

Wei, Haoche; Li, Yanan; Li, Li; Hu, Qian; Shi, Mingsong; Cheng, Linbo; Jiang, Xile; Zhou, Yanting; Chen, Siyuan; Ji, Yi; Chen, Lijuan

Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods

利用计算工具和实验方法阐明姜黄素与人盐诱导激酶3之间的相互作用

Shi, Mingsong; Zhou, Yan; Wei, Haoche; Zhang, Xinyu; Du, Meng; Zhou, Yanting; Yin, Yuan; Li, Xinghui; Tang, Xinyi; Sun, Liang; Xu, Dingguo; Li, Xiaoan

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations

基于分子动力学模拟的吡咯并吡啶酮类似物靶向含溴结构域蛋白4的溴结构域2的选择性机制

Shi, Mingsong; Zheng, Xueting; Zhou, Yan; Yin, Yuan; Lu, Zhou; Zou, Zhiyan; Hu, Yan; Liang, Yuanyuan; Chen, Tingting; Yang, Yuhan; Jing, Meng; Lei, Dan; Yang, Pei; Li, Xiaoan